Joe Manganiello says a 7-year autoimmune health battle left him in chronic pain and ended with a life-saving organ amputation. He is laying out the ordeal in Bloodlines, turning a private medical collapse into the book’s central disclosure before its Oct. 13 release.
Bloodlines and June 23
On June 23, Manganiello said the chapter was the most difficult time of his life and called it “one I wouldn't wish on my worst enemy.” The memoir’s synopsis says his body began to fail him without warning, then details how autoimmune-related illnesses attacked his skin, thyroid, eyes, lungs, and digestive system.
That sequence tells readers this was not a single diagnosis but a cascade across multiple systems, the kind of illness pattern that can turn routine life into a moving target. Manganiello says he wants the book to leave readers with hope that answers and healing can come after the worst stretch of the fight.
Seven Years of Pain
The seven-year timeline is the most important number in the story. It places the health battle across a long stretch of Manganiello’s working life, even as he was publicly associated with a soaring career, a new engagement to Caitlin O'Connor in October, and the kind of physique that usually signals control rather than crisis.
He has also spoken before about the effort behind that body. In March 2025, he described a bloodwork-heavy approach to nutrition, saying, “When you eat, you're guessing, or you're just following some fad diet you just read about,” and adding, “Chris will take 10 vials of your blood. Then, three weeks later, you get 26 pages of results. It's you specifically. What you're supposed to eat. What your genetic history tells you to eat.”
That earlier interview does not explain the autoimmune battle, but it does show how closely Manganiello has tied his health to measurement, discipline, and response rather than image alone. Bloodlines now shifts the focus from performance to vulnerability, and from physique to survival.
Oct. 13 Release
Bloodlines is scheduled for Oct. 13, giving readers a fixed point for when Manganiello’s account will arrive in full. The memoir is the next piece to watch, because it is the first place he is positioning the health crisis as a public record rather than a fragment of an interview.
For readers, the practical takeaway is simple: Manganiello has already disclosed the scale, duration, and severity of the illness, but not the exact autoimmune diagnosis or which organ was removed. The book should answer the story’s biggest medical gaps, and it will do so through his own account rather than rumor or replay.
That is the value here. A 7-year illness that reached his organs is no side note to his career or his image; it is the event that now defines what Bloodlines is for.
